< Back to Article

Effectiveness and economic assessment of routine larviciding for prevention of chikungunya and dengue in temperate urban settings in Europe

Fig 5

Probability of highest net health benefit for a single larvicide application according to the type of intervention (none vs. public vs. public and private), by year, coverage (30 and 50% for public intervention; 60 and 75% for both public and private intervention) and study site.

Fig 5